Tr1x

Tr1X is pioneering a revolutionary category of regulatory T cell-based products aimed at curing autoimmune and inflammatory diseases, with the potential to significantly improve the lives of patients.

Country
USA
Website
Founded
2018
Social
Source of information: 

www.tr1x.bio/

Add to My List
Key Executives

Bill Lis

Chief Executive Officer

Maria Grazia Roncarolo, MD

Co-founder, President and Head of R&D

David de Vries, MPhil

Co-founder, Chief Operating Officer

Industries